181 related articles for article (PubMed ID: 35235139)
41. Pharmacological characterization of a structural hybrid P2X7R antagonist using ATP and LL-37.
Jackson A; Werry EL; O'Brien-Brown J; Schiavini P; Wilkinson S; Wong ECN; McKenzie ADJ; Maximova A; Kassiou M
Eur J Pharmacol; 2022 Jan; 914():174667. PubMed ID: 34863711
[TBL] [Abstract][Full Text] [Related]
42. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
[TBL] [Abstract][Full Text] [Related]
43. Activation of P2X7 receptors decreases the proliferation of murine luteal cells.
Wang J; Liu S; Nie Y; Wu B; Wu Q; Song M; Tang M; Xiao L; Xu P; Tan X; Zhang L; Li G; Liang S; Zhang C
Reprod Fertil Dev; 2015 Nov; 27(8):1262-71. PubMed ID: 25782073
[TBL] [Abstract][Full Text] [Related]
44. Involvement of P2X
Ji Z; Xie Y; Guan Y; Zhang Y; Cho KS; Ji M; You Y
Biomed Res Int; 2018; 2018():8591397. PubMed ID: 29546069
[TBL] [Abstract][Full Text] [Related]
45. Purinergic modulation of frog electroretinographic responses: The role of the ionotropic receptor P2X7.
Kupenova P; Popova E; Vitanova L
Vis Neurosci; 2017 Jan; 34():E015. PubMed ID: 28965497
[TBL] [Abstract][Full Text] [Related]
46. [P2X7R promotes migration and invasion of Lewis lung cancer cells by activating the AKT signaling pathway].
Tang Y; Zhao R; Qiao C; Li X; Bai X; Peng X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1495-1502. PubMed ID: 36329583
[TBL] [Abstract][Full Text] [Related]
47. P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastoma.
Kan LK; Drill M; Jayakrishnan PC; Sequeira RP; Galea E; Todaro M; Sanfilippo PG; Hunn M; Williams DA; O'Brien TJ; Drummond KJ; Monif M
Sci Rep; 2023 May; 13(1):8435. PubMed ID: 37225786
[TBL] [Abstract][Full Text] [Related]
48. Synthetic 1,4-Naphthoquinones inhibit P2X7 receptors in murine neuroblastoma cells.
Pislyagin E; Kozlovskiy S; Menchinskaya E; Chingizova E; Likhatskaya G; Gorpenchenko T; Sabutski Y; Polonik S; Aminin D
Bioorg Med Chem; 2021 Feb; 31():115975. PubMed ID: 33401207
[TBL] [Abstract][Full Text] [Related]
49. The P2X7 receptor links mechanical strain to cytokine IL-6 up-regulation and release in neurons and astrocytes.
Lu W; Albalawi F; Beckel JM; Lim JC; Laties AM; Mitchell CH
J Neurochem; 2017 May; 141(3):436-448. PubMed ID: 28244110
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms of Mg2+ inhibition of BzATP-dependent Ca2+ responses in THP-1 monocytes.
Jantaratnotai N; McGeer PL; McLarnon JG
Brain Res; 2012 Mar; 1442():1-8. PubMed ID: 22297175
[TBL] [Abstract][Full Text] [Related]
51. Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP.
Young MT; Pelegrin P; Surprenant A
Mol Pharmacol; 2007 Jan; 71(1):92-100. PubMed ID: 17032903
[TBL] [Abstract][Full Text] [Related]
52. Purinergic P2X7 receptor mediates acetaldehyde-induced hepatic stellate cells activation via PKC-dependent GSK3β pathway.
Wu X; Wang Y; Wang S; Xu R; Lv X
Int Immunopharmacol; 2017 Feb; 43():164-171. PubMed ID: 28061416
[TBL] [Abstract][Full Text] [Related]
53. P2X7 receptor antagonists: a patent review (2010-2015).
Park JH; Kim YC
Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
[TBL] [Abstract][Full Text] [Related]
54. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
Lee S; Ha H; Jang J; Byun Y
Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
[TBL] [Abstract][Full Text] [Related]
55. Exploratory study of oxatomide derivatives with high P2X
Yamagiwa N; Komine M; Hanaoka F; Nobuta T; Yoshida K; Ito M; Matsuoka I
Bioorg Med Chem Lett; 2022 Dec; 77():129035. PubMed ID: 36283612
[TBL] [Abstract][Full Text] [Related]
56. Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1.
Di Cesare Mannelli L; Marcoli M; Micheli L; Zanardelli M; Maura G; Ghelardini C; Cervetto C
Neuropharmacology; 2015 Oct; 97():133-41. PubMed ID: 26071109
[TBL] [Abstract][Full Text] [Related]
57. Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis.
Caragnano M; Tortorella P; Bergami A; Ruggieri M; Livrea P; Specchio LM; Martino G; Trojano M; Furlan R; Avolio C
J Neuroimmunol; 2012 Apr; 245(1-2):93-7. PubMed ID: 22370183
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of P2X7 Purinergic Receptor Ameliorates Cardiac Fibrosis by Suppressing NLRP3/IL-1
Zhou J; Tian G; Quan Y; Li J; Wang X; Wu W; Li M; Liu X
Oxid Med Cell Longev; 2020; 2020():7956274. PubMed ID: 32566102
[TBL] [Abstract][Full Text] [Related]
59. P2X7 Receptor Suppression Preserves Blood-Brain Barrier through Inhibiting RhoA Activation after Experimental Intracerebral Hemorrhage in Rats.
Zhao H; Zhang X; Dai Z; Feng Y; Li Q; Zhang JH; Liu X; Chen Y; Feng H
Sci Rep; 2016 Mar; 6():23286. PubMed ID: 26980524
[TBL] [Abstract][Full Text] [Related]
60. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
